Physician

Harleen Aujla, M.D.

According to 2025 Medicare claims, Harleen Aujla, M.D. (NPI: 1144661000) practices internal medicine in the Merced, CA market, with the plurality of this provider's patient population coming from Merced, CA. This provider's primary affiliated billing organization is MERCED TURLOCK NEPHROLOGY MED GROUP INC. (NPI: 1902997984; TIN: 870742343) and primary practice location at 95340-2800. Aujla is affiliated with the Aledade 45 CA CHC MSSP Enhanced (ACO ID: A4542), participating under the MSSP model.

Aujla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 364 traditional Medicare patients, billed 1,629 HCPCS/CPT codes, and received $191,052 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,144 prescription claims across 202 beneficiaries totaling $198,704 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2018 DME data shows 61 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,369 to $198,704. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	387	1,411	$132,572
2020	486	2,014	$191,102
2021	440	1,883	$199,371
2022	377	1,599	$185,314
2023	348	1,638	$194,950
2024	364	1,629	$191,052

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	20	82	$3,369
2017	16	61	$1,664
2018	51	134	$17,904
2019	117	586	$50,737
2020	135	730	$88,542
2021	145	769	$72,643
2022	143	932	$97,011
2023	140	979	$135,930
2024	202	1,144	$198,704

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	44	$2,169
2018	N/R	61	$2,440
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	83	90	$126
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	83	95	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	136	265	$87
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	150	527	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	109	131	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	51	3,330	$59,357
Jardiance	Empagliflozin	44	2,280	$41,919
Lokelma	Sodium Zirconium Cyclosilicate	16	1,109	$20,060
Sevelamer Carbonate	Sevelamer Carbonate	82	4,358	$13,258
Veltassa	Patiromer Calcium Sorbitex	12	419	$7,546

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Harleen Aujla, M.D.?

Tedicare shows public-source Medicare data for Harleen Aujla, M.D. (NPI 1144661000), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Harleen Aujla, M.D. have ACO affiliation data?

Harleen Aujla, M.D. is shown with ACO affiliation data for Aledade 45 CA CHC MSSP Enhanced (MSSP, ACO ID A4542).

What billing organization is linked to Harleen Aujla, M.D.?

Harleen Aujla, M.D. is linked to MERCED TURLOCK NEPHROLOGY MED GROUP INC. (billing NPI 1902997984) in the available physician profile data.

Does Harleen Aujla, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.